Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Androgen Deprivation Therapy (ADT) & Prostate cancer

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Injectable luteinizing hormone–releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and delay in therapeutic effect.
Shore et al. 2020 NEJM 382: 2187-2196

…

References (Sources)

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
Chi et al. 2019 N Engl J Med 381: 13-24
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
Chi et al. 2021 JCO 39: 2294–2303
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Armstrong et al. 2022 J Clin Oncol 40: 1616-1622
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Shore et al. 2020 NEJM 382: 2187-2196

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Androgen Deprivation Therapy (ADT) & Prostate cancer

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat